Language selection

Search

Details for: MAVIRET

Company: ABBVIE CORPORATION

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02522470MAVIRETGLECAPREVIR; PIBRENTASVIR50 MG / SACHET; 20 MG / SACHETGRANULESORAL
02467550MAVIRETPIBRENTASVIR; GLECAPREVIR40 MG; 100 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary
Regulatory Decision Summary
Regulatory Decision Summary
Regulatory Decision Summary
Summary Safety Review - Direct-acting antivirals - Assessing the potential risk of abnormal blood sugar levels (dysglycemia)
Summary Safety Review - Direct-Acting Antivirals - Assessing the Potential Risk of New or Returning Liver Cancer named Hepatocellular Carcinoma
Summary Safety Review - Direct-acting antiviral products containing a Protease Inhibitor - Assessing the Potential Risks of Hepatic Decompensation and Hepatic Failure

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: